SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-024527
Filing Date
2020-05-12
Accepted
2020-05-12 11:13:33
Documents
3
Period of Report
2020-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evok-8k_20200512.htm 8-K 34859
2 EX-99.1 evok-ex991_6.htm EX-99.1 187519
3 GRAPHIC glsqe1fcjs3y000001.jpg GRAPHIC 4748
  Complete submission text file 0001564590-20-024527.txt   230207
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 20867564
SIC: 2834 Pharmaceutical Preparations